Cargando…
Metabolic syndrome – Removing roadblocks to therapy: Antigenic immunotherapies()
Up to 25 per cent of the world׳s adult population may have the metabolic syndrome, a condition closely associated with central obesity. The metabolic syndrome is a major risk factor for cardiovascular disease and type 2 diabetes and therefore represents an important worldwide health problem. In addi...
Autores principales: | Coppieters, Ken T., von Herrath, Matthias G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986497/ https://www.ncbi.nlm.nih.gov/pubmed/24749057 http://dx.doi.org/10.1016/j.molmet.2013.12.005 |
Ejemplares similares
-
The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes
por: Coppieters, Ken, et al.
Publicado: (2018) -
Non-antigenic and antigenic interventions in type 1 diabetes
por: Rydén, Anna KE, et al.
Publicado: (2013) -
The Type 1 Diabetes Signature: Hardwired to Trigger Inflammation?
por: Coppieters, Ken T., et al.
Publicado: (2014) -
Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010) -
Biosimilars Adoption: Recognizing and Removing the RoadBlocks
por: Niazi, Sarfaraz K
Publicado: (2023)